Effect of transcatheter arterial chemoembolization on kidney hemodynamics and function in patients with cirrhosis and hepatocellular carcinoma

Journal of Hepatology

Volumn 31, Issue 2, 1999, Pages 340-346

  Nakano, Ryohichi ^a   Iwao, Tadashi ^a   Oho, Kazuhiko ^a   Ono, Naofumi ^a   Sakai, Teruhiro ^a   Sato, Masahiro ^a   Yamawaki, Makoto ^a   Miyamoto, Yasunao ^a   Sakai, Kenji ^a   Takeda, Teiko ^a   Tsuruta, Osamu ^a   Sata, Michio ^a   Toyonaga, Atsushi ^a  

^a Div Gastroenterol Endoscopy   (Japan)

Author keywords

Cirrhosis; Doppler ultrasonography; Endothelin 1; Hepatocellular carcinoma; Kidney function; Noradrenaline; Plasma renin activity; Portal vein; Pulsatility index; Renal artery

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOTHELIN 1; EPIRUBICIN; FARMORBICIN; GELFOAM; IODINATED POPPYSEED OIL; NORADRENALIN; RENIN; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; PLASMA RENIN ACTIVITY; PORTAL VEIN; PRIORITY JOURNAL; PULSATILE FLOW; RENAL ARTERY; SAFETY;

EID: 0032797187     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80233-5     Document Type: Article

References (38)

1. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma. Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology. 163:1987;345-351.
2. Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology. 140:1981;51-58.
3. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 148:1983;397-401.
4. Nakamura H, Hashimoto T, Ohi H. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 170:1989;783-786.
5. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 163:1992;387-394.
6. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire Comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 332:1995;1256-1261.
7. Pelletier G, Roche A, Ink O, Anciaux M, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol. 11:1990;181-184.
8. Bianco S, Merkel C, Savastano S, Bellon S, Chiesura-Corona M, Bolognesi M, et al. Short-term effects of transcatheter arterial chemoembolization on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma. Gut. 39:1996;325-329.
9. Miyoshi S, Minami Y, Kawata S, Imai Y, Saitoh R, Noda S, et al. Changes in metabolic activity of the liver reserve after transcatheter embolization of hepatocellular carcinoma. J Hepatol. 6:1988;332-336.
10. Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol. 13:1990;135-139.
11. Stuart K, Stokes K, Jenkins R, Trey C, Clouse M. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer. 72:1993;3202-3209.
12. Khan KN, Nakata K, Shima M, Kusumoto Y, Ishii N, Koji T, et al. Pancreatic tissue damage by transcatheter arterial embolization for hepatoma. Dig Dis Sci. 38:1993;65-70.
13. Hirakawa M, Iida M, Aoyagi K, Matui T, Akagi K, Fujishima M. Gastroduodenal lesions after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Gastroenterol. 83:1988;837-840.
14. D'Elia JA, Gleason RE, Alday M, Malarick C, Godfrey K, Warran J, et al. Nephrotoxicity from angiographic contrast material: a prospective study. Am J Med. 72:1982;719-725.
15. Porter GA. Experimental contrast-associated nephropathy and its clinical implications. Am J Cardiol. 66:1990;18F-22F.
16. Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Renal vasoconstriction in cirrhosis evaluated by Duplex Doppler ultrasonography. Hepatology. 17:1993;219-224.
17. Pugh RNH, Murray-Lyron M, Dawson JL, Pietroni MC, Williams R. Transsection of oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
18. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa M, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 56:1985;918-928.
19. Menard J, Guyenne TT, Corvol P, Pau B, Simon D, Roncucci R. Direct radioimmunoassay of active renin in human plasma. J Hypertens. 3:(suppl 3):1985;S275-S278.
20. Yamatodani A, Wada H. Automated analysis for plasma epinephrine by liquid chromatography, including a sample cleanup procedure. Clin Chem. 27:1981;1983-1987.
21. Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M. A sensitive sandwich-enzyme immunoassay for human endothelin. J Immuno Methods. 118:1989;245-250.
22. Looyenga DS, Liebson PR, Bone RC, Balk RA, Messer JV. Determination of cardiac output in critically ill patients by dual beam Doppler echocardiography. J Am Coll Cardiol. 13:1989;340-347.
23. Taylor KJW, Holland S. Doppler ultrasound. Part 1. Basic principles, instrumentation, and pitfalls. Radiology. 174:1990;297-307.
24. Iwao T, Toyonaga A, Shigemori H, Oho K, Sakai T, Tayama C, et al. Hepatic arterial hemodynamic responsiveness to altered portal blood flow in healthy and cirrhotic livers. Radiology. 200:1996;793-798.
25. Iwao T, Oho K, Nakano R, Yamawaki M, Sakai T, Sato M, et al. Effect of meal-induced splanchnic arterial vasodilatation on renal arterial hemodynamics in normal subjects and patients with cirrhosis. Gut. 43:1998;843-848.
26. Taourel P, Dauzat M, Lafortune M, Pradel J, Rossi M, Bruel JM. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinoma. Radiology. 191:1994;189-192.
27. McCallum WD, Williams CS, Napel S, Daigle RE. Fetal blood velocity waveform. Am J Obstet Gynecol. 132:1978;425-429.
28. Norris CS, Barnes RW. Renal artery flow velocity analysis: a sensitive measure of experimental and clinical renovascular resistance. J Surg Res. 36:1984;230-236.
29. Rigsby CM, Taylor KJW, Weltin G, Burns PN, Bia M, Princenthal RA, et al. Renal allografts in acute rejection: evaluation using Duplex sonography. Radiology. 158:1986;375-378.
30. Platt JF, Rubin JM, Ellis JH. Acute renal failure: possible role of Duplex Doppler US in distinction between acute prerenal failure and acute tubular necrosis. Radiology. 179:1991;419-423.
31. Bardelli M, Jensen G, Volkmann R, Aurell M. Non-invasive ultrasound assessment of renal artery stenosis by means of the Gosling pulsatility index. J Hypertens. 10:1992;985-989.
32. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, et al. Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet. 8630:1989;53-54.
33. Lerman A, Click RL, Narr BJ, Wiesner RH, Krom RAF, Textor SC, et al. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplant. 51:1991;646-650.
34. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res. 69:1991;370-377.
35. Deray G, Jacobs C. Radiocontrast nephrotoxicity: A review. Invest Radiol. 30:1995;221-225.
36. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 89:1990;615-620.
37. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 86:1989;649-652.
38. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JS, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 8:1988;1151-1157.